Volume 15 Number 19 1987                                              Nucleic Acids Research
 n d sequence PRII gene relaed DNA prime Sacchwomyces cerevsae


Paolo Plevani*, Stefania Francesconi Giovanna Lucchini


Dipartimnto di Genetica e Biologia dei Microrganismi, Universita di Milano, Celoria 26, 20133
Milano, Italy

Received July 30, 1987; Revised Accepted September 11, 1987                Accession  Y00458


ABSTRACT PRIl gene Saccharomyces cerevisiae encodes p48 polypeptide DNA primase. determined nucleotide sequence 1,965 bp DNA
fragment containing PRIl locus. entire coding sequence gene
lies open reading frame, 409 amino acids single polypeptide protein translation assumed start ATG frame. 5' 3' end-points PRIl mRNA determined Sl mapping primer extension analysis. primary structure codon usage PRIl suggest essential gene poorly expressed yeast cells.


INTRODUCTION
Purified DNA polymerases prokaryotic eukaryotic organisms unable initiate DNA synthesis novo (1). evidences indicate nascent DNA chains (Okazaki fragments), lagging strand replication fork, synthesized elongation RNA primers (1). specialized enzyme, called DNA primase, devoted synthesis oligoribonucleotides, involved initiation DNA replication (1).
Recently, DNA primase activity associated 
plicative DNA polymerase purified variety eukaryotic organisms (2). polypeptide structure catalytic activity DNA polymerase-
DNA primase complexes appear highly conserved, suggesting play critical role DNA replication. mechanism priming leading strand origin replication similar initiation synthesis lagging strand, proposed eukaryotic DNA polymerase-primase complexes involved forma-



 ) R L Press Limited, Oxford, England.                                                      7975
 Nucleic Acids Research

tion initiation complex, simply function elongation reaction  review, ref.2). purified yeast DNA polymerase-primase complex rapid immuno-
affinity chromatography using mouse monoclonal antibody (3). catalytic
subunit exhibiting hetherogaeros   composition antigenically related poly-
peptides, ranging 140 kDa 180 kDa, identified DNA
polymerase core enzyme (3,4). corresponding gene cloned using specific antibodies, Southern analysis gene disruption experi-
ments showed yeast DNA polymerase encoded single, essential
gene (5-7). mechanistic properties yeast DNA primase exten-
sively characterized, enzymatic activity easily disso-
ciated DNA polymerase  eventually, bifunctional complex reconstituted vitro (3,8). DNA primase, yeast eukaryotic organisms, correlates polypeptides approximately
48 kDa 58 kDa (2). known yeast p48
polypeptide itself sufficient DNA primase activity, antiserum
raised isolated polypeptide inhibits enzymatic activity, providing direct evidence protein related DNA
primase (4). isolated gene encoding p48 polypeptide using specific antiserum demonstrated unique yeast haploid
genome function essential (4). called gene PRII, cloned gene related eukaryotic DNA primase. order facilitate studies mechanistic functional pro-
perties DNA primase, undertook determination nucleotide se-
quence PRIl gene. knowledge sequence essential overproduce p48 polypeptide yeast E.coli, construct
thermosensitive mutants site directed mutagenesis analyze regu-
lation expression essential enzyme involved DNA replication.  knowledge sequence yeast DNA primase helpful identifying genes performing similar functions eukaryotic cells. analysis sequence 1,965 bp segment containing entire PRIl
gene revealed presence open reading frame 1,227 nucleotides encodes protein 47,623 daltons. mapping 5' 3'


7976
                                                                              Nucleic Acids Research

end-points PRIl mRNA provides necessary information study mecha-
nisms controlling PRIl transcription.


MATERIALS METHODS
Subcloning construction deletions spanning PRIl gene. cloning PRIl           gene   Saccharomyces cerevisiae reported
previously (4). pGEM series plasmids (Promega Biotec.,Cambridge,MA)
containing      polylinker cloning segment flanked T7 SP6 promoters                     
used sequencing work reported  PRIl coding sequence                          

tained        1.92 kb NruI-SstI fragment (4),                ligated SmaI SstI sites plasmid pGEM-2, create derivative plasmid pPP1.
Exonuclease III           used construct      set unidirectional deletions            ac-

cording procedure described Henikoff (9). exonuclease III
fails initiate digestion DNA ends base 3'-protrusions digestion    progresses          uniform rate,      ordered set deletion clones 5' 3' direction PRIl             gene      cutting pPPl BamHI PstI exonuclease treatment. fact,                           enzymes

cut plasmid              polylinker region, BamHI              pro-

ximal PRII insert, PstI leaves                    3' base protrusion protects remainder vector nuclease attack. Aliquots                           

moved exonuclease III digestion mixture uniform intervals, trea-
ted Sl nuclease, Klenow DNA polymerase, T4 DNA ligase used transform E.coli competent cells (9). Plasmid DNA                     prepared transformants time point extent deletions                           determi-
ned restriction analysis. Sequencing PstI-NruI region shown Figure 1 sequencing opposite DNA strand                      achieved subclo-
ning appropriate restriction fragments pGEM-2 vector using T7            SP6 promoter primers.     case,       sequence   3' 5' direction           portion PRIl   gene        obtained using        primer sequencing reaction              20-mer synthetic oligonucleotide complementary sequence opposite strand previously determined.
DNA sequencing. subclones            sequenced dideoxy-chain termination method (10),


                                                                                                    7977
 Nucleic Acids Research

using denatured plasmid templates (11). Preparation plasmid DNA alka-
line denaturation performed essentially described (11). sequen-
cing reactions carryed Promega GemSeq       K/RT accor-
ding instructions manufacturer, using[     5S]-dATP   labeled
nucleotide. Klenow fragment E.coli DNA polymerase generally used, AMV reverse transcriptase utilized resolve ambiguities 
tually sequence ladder obtained enzyme.
Preparation RNA transcript mapping 5' 3' end-points.
Poly     yeast RNA prepared strain TD28 (MATa, ura3.52, inosl, canl) previously described (4). Sl nuclease protection experiments car-
ryed essentially described Natsoulis et al. (12). probes map 5' 3' end-points PRIl transcript  respectively, NruI-ScaI NdeI-SstI fragments plasmid pPP1 labeled T4 polynucleo-
tide kinase ScaI site Klenow enzyme NdeI site. fragments hybridized 20 40 pg poly       RNA quantities S1 required complete digestion non-protected fragments 
termined empirically. Protected DNA electrophoresed 6  polyacrylami- denaturing gel parallel Maxam Gilbert sequence (13) fragments used S1 mapping experiments. primer extension experiment synthetic primer 5' GTCTTTAC
TGAATTGGTCAT 3' complementary PRIl mRNA (+1 +20) synthesized Applyed Biosystems DNA synthesizer. primer hybridized 20 40 pg   poly +   RNA extended AMV reverse transcriptase presence     _P]-TTP labeled nucleotide essentially described Giaver et al. (14). products reaction analyzed 8  se-
quencing gel Sanger sequencing reaction plasmid pPP1 
formed using synthetic oligonucleotide primer. assisted analysis DNA sequence.
DNA sequence data deduce amino acids composition PRIl protein, codon usage hydrophilicity profile analyzed IBM
microcomputer using MicroGenie program (Beckman).




7978
                                                                     Nucleic Acids Research

                                           PRI ORF                    >

                         4
                              -*
     Pstl             Nrul    ScalEcoRI NindAll Acci         BglH       Ndel    Ball     Sstl

                                            - *          -          *          --

             0.5 kb


Figure 1. Restriction map DNA sequencing strategy PRIl region. horizontal lines arrowheads indicate extent direction sequenced fragments. extent PRIl open reading frame indica-
ted figure.

RESULTS DISCUSSION
Sequencing strategy. cleavage sites number 6 bp restriction enzymes previously
cloned 2,450 bp region containing entire yeast PRIl gene shown Figure 1. previous experiments known coding sequence located right NruI site terminated SstI site. fact, 1.45 kb mRNA identified PRIl mRNA detected Northern blots yeast poly         RNA using DNA probes spanning NruI-BalI region. upstream PstI-NruI fragment SstI-NcoI fragment,
spanning 1 kb region downstream SstI site, identified Northern blots mRNA species 0.92 kb 2.25 kb respectively (data shown), correspond transcripts unidentified yeast genes lie PRI1 locus. direction transcription PRIl gene known left right demonstrated vitro
transcription translation pGEM-2 derivative plasmid                    NruI-SstI fragment inserted control phage T7                   promoter(4). generate plasmids direct sequencing dideoxy-chain termination
method      (10), plasmid pPP1 containing NruI-SstI fragment inserted polylinker region pGEM-2, cut PstI BamHI set targeted
5,     deletions created unidirectional digestion exonuclease III described Materials Methods. number overlapping deletions se-


                                                                                            7979
 Nucleic Acids Research

quenced using denatured plasmid template phage T7 promo-
ter primer directly   obtain sequence mRNA (non-coding) strand PRIl gene. opposite DNA strand sequenced subcloning suitable restriction
fragments pGEM plasmids using T7 SP6 phage promoter primers synthetic oligonucleotides complementary proper regions previously
determined non-coding strand PRIl gene (15). large majority clones yielded high quality sequencing ladders, purity plasmid
DNA crucial DS sequencing method (11).
Nucleotide sequence yeast PRIl gene.
Figure 2 depicts sequence 1,965 bp PRIl region yeast
Saccharomyces cerevisiae, previously located chromosome IX (4). indicated restriction sites deduced nucleotide sequence complete agreement independently restriction map shown Figure 1, limits agarose gel resolution. Furthermore, enti- coding sequence yeast PRIl gene contained NruI-SstI 
gion restriction map, deduced previous data (4). open reading frame (ORF) encoding 409 amino acids ending TGA
stop signal identified sequence. 1,227 bp ORF encodes polypeptide calculated molecular weight 47,623 daltons, provided ATG downstream transcription start recognized translation machinery. PRIl encodes polypeptides yeast DNA primase polypeptide mass enzyme subunit estimated 48,000 daltons electrophoretic mobility polyacrylamide gel presence sodium dodecyl sulfate (3).  appears molecular weight PRI1 protein deduced DNA se-
quence analysis p48 polypeptide yeast DNA primase complete agreement. second frame ATG codon nucleotides +45 +47 act initiator codon generate protein slightly reduced
molecular weight 46,210 daltons reasonable accor-
dance peptide mass DNA primase determined electrophoretic ana-
lysis. gene encoding yeast hystidine-tRNA synthetase (HTS1) 

7980
                                                                                                                     Nucleic Acids Research
           -30                                           llru
           IItAGCllCC GIJACTGGIT CAGCCACAGG IGIGAIGAGI CGCGAICA AICCICGCCI ItiICCIIGC ICCIICAACC AIIACIATAI CCIACGICIL
           AA^GAIGCGI GAGIIICGAA ACAGTIGCIC GGICAGIGCC CIIIGCCACI IIIACCIAII CIllIClIlC AGIIGAAAAG IJICAIAACG CCAAAAAGAI
           -100                                                    _                   _
           AAAAAAIIAA TCAAAAAAIC ITIGAAGCIG AAGAGAAAAL CGIGCCAIAA TACIALCAAA AAIIACIIII AGCAACICAA AAAACICIII IAIAAACAIC
                                                                                 Scal
   A1G ACC AA! ICA G61 AAG ACT AA G66G CCA AGC ICC 1CA
   Net Ihr Asn Ser Va Lys Thr Asn Gly Pro Ser Ser Ser JAC
                                                          AVG G6G TAC TAC TAT AAG ICC CIC 1Al CCA IIC AAA CAC IIC AAC
                                                       sp Net G u Tyr Tyr lyr lys Ser leu Tyr Pro Phe lys                                                                                                             r Phe sn
   91                                                           [coRI
   T6G CIG AA1 CST 1CG CCC AAA CCI lCl AGG GAl AVG AAC AA GSA ItC GC6 AIG 6CG IIC AGG ICA GG6 CC1 IAC AAA ACG IA AAI
   Trp Leu Asn Ser Pro Lys Pro Ser Arg Asp Net lIe  Arg Glu Phe Ala let Al Phe Arg Ser Cly Ala ly Iys Arq Tyr
                                                                                                                    yAn
   181
   IC! 111 AAC IC! GIG CAA GA! TIC AAA 6CA                 AlA
                                                  GAA AAA GCC AAC CCA GAC AGA 111 GA        G66 GCC    Ser Phe  Ser Val G6n Asp Phe Lys Ala G1 lIe 6lu Lys Ala Asn Pro sp Arg Phe G lu llICe Gly Ala Ile 1Ayr Asn lys Pro Pro
                                                                                                             AAC AAA CCG CCA

   271                                           Hind IIl
   AGA GAu GT GAI AC! CIA IIA AAA NC UA 1G AAA 661 IIA GAG AACGCCG 16 GIG                 GAl AIG GAl GAl IAC IAl GCC lIC
           Arg Asp Thr Leu lem Lys Ser 61u lea Lys la Lev G61 Lys C u leu Val Phe Asp                                                                           G GI  1    Arg Giu                                                                                p flet Asp Asp yr sp Ala Phe
   361
   AGA ACG 1GT IGC ICC CGA 6CC C 611 IGC ICT AAG IGC 1GG AAA Ti1                        II     C CGCGC AG AA IACG AC ACC        CI GA G
   Arg Thr Cys CysSer Gly AlaGlnnaI Cys Ser Lys Cys Trp Lys Phe                            e Ser    lee la Net lys lIe Ihr Asn Ihr la leu Aq Clu
   451                                                                Accl
   GA 1T              TAT AAG JAC ITC AIC
                         1^                    1GG GTA   11 ICA    G66 AGAC6661G     G ITC IC16 GG GIA AGC GAC AAA CGG GCA CGG Gi               ACC
                                                                                                                                            II Ihr
    sp Phe          y    Tyr Lys sp e     Irp Va    Phe Ser   Gly Arg Arg G   y Cys Trp VaI Ser Asp lys Arq Ala Arq          teu
   541
   GA!     Gl CA CGA AGA AAC G61 TIA GAl IA! 61C AAC Gl AGA AC AGA AA1 ACI GAC AAG CGA 11
           Va Gn Arg Arg Asn Va leu sp yr Va sn Val e Arg Asprg Asn Thr sp Lys Arg teu
                                                                                           IG                            l II   AAG AGG CCI IA! CAC
                                                                                                                                        Pro lyr     sp                                                                                                                     teu lys Arg
   631
   CCI CAT Cll GfT CGI IC! 11G GfG
   Pro lev aArg Ser Lev G6 G.n leu Lys Pro Phe Phe Va AVSer
                                   CA I16 AAA CCI IIC TI1 G                            Alf IG      CIC G JAC GCA AI CCI IGG       GAl GAC CfA C#1
                                                                                                   teu himu Asp GTu Asn Pro lrp GfA
                                                             GC
                                                                                        e Net                                   GTu Asp Csp 61n    771
   l AII Ce
           CtAa ATCIlA11 G            CIACl
                                         IVA      IA!
                                                  GTAl       AAA CAIA GA16 l CAl ICA IIA AAG AAG IA! IG CIC GAC AAI CCA AGG AGG ICA AGC
                TI r leu Leu            Leu  lyr sp     Lys G n Leu e Asp Ser leu lys Lys lyr lrp leu Asp Asn Pro Arg Arg Ser Ser
   oil
    GAG AAG   166  AAT GA!         AlA GAl CAG AlA 661     ACA ICG CIC IIC AAA GGC CCC AAG 61.
                                                                                               AGAC ICT CAC                         1GI
                                                                                                            lIe                                                                                                                 lIe Lys lea Arg G                                                                                                                     AAG llA CGt
   Lys 61u Lys lrp Asc sp            le Asp G6n e Ala    Ihr Ser teu Phe Lys Gly Pro Lys C! Asp Ser AIA                 Clu Cys
   901           1111I
   AAG GGAlT CIC lIA 1G AIG  AC! CII IA! CCG AAG CIG GA! GIG G ACA AAG CfA ACA CAl 11G ITA AAG 6CC CCI TIIT GI
                         Net Thr Lee Tyr Pro Lys leu Asp Val G61 G!G
   Lys 61U Asp Lee alteu                                           Vat Ihr Lys G61 Ihr lIe leu leu Lys Ala Pro Phe Cys
   991
   AllIe   l CA GCTIJ AP GCG AAT GTC IG6 G61 CCI Al! GAl G6A ICC IIT C6A CCT GAA AAA GCA CCI AAG CIA GAl CIT CAA ACA CGA
            Pre Ihi Gly Asn Val Cys Val Pro lIe sp G u Ser Phe Ala Pro G6u Lys la Pro lys leu lIe Asp teu G6n Ihr Clu
   10111                                                                                                      del
       G16 HG AAA AAI AA! GA! GIl ICA lA ACA 66! TIA CAA CCI 11 IIC
                                                                  CAA CfG lC CAGA IA! GIG AGT IC! CTI IIC AAA AAI CAA
        let u Lys sn Asn sp Va Serieu Thr       leu G Pro Phe       Asn G n Phe Gln la Tyr Va Ser Ser leu leu lys Glu
                                                                                   e




   1111
   CICG 66 ICA GIG AAA AGA GAA CGI GIA GA! GA! GAl GAA CCC 661 IC! hA CGA TIC IGA IGGIGAAAIC TTTIIGTAAC AAIAAAAAG(.
   tea Gly Ser al Lys Arg G Arg G1u Asp sp Asp Glu Pro Ala Ser leu Asp Phe *ue

           ltrZIAIAIAA      AITIAITAGA CIACIAIAGC IITIGGIICA AIITIGCIIT ACCIGTAAAC GCATTCCCT GGTAAGTCAI ICGAAGAGCC ACIICCACAG!
                 1361
                    *--                                             Ball
                 6IIGGCC IIGACITCCA      IlIIGCGCAA AITICAATGA ACTCAICGCC AGCCICCCGA AACCAITCAA GAACCTGGTA CTCAGCTTTA IACGIAIAAI
            tLGIAIGA IGAACGAAIT GACAACCGCC TICIGGAAA AIGGCGCCCCI CCIAIAAAAA TAAATAGGG GACAGTTATC TGTTCGCGCG IM.LIIfAI
            M AAIIC AAAAGGTAGG AITIAITACA IAAGFTAAAC ICAGCAAACI CAAAICITCC GGAAIFTTGC AIGGGGAATI GGICICAIIV IA(CAICOAA
           1I9
           AGCIC


Figure 2. Nucleotide sequence deduced amino acids sequence PRI1. nucleotide sequence numbered ATG initiation codon PRIl
protein (+1). amino acids sequence translated DNA se-
quence. major 51 end-points mature PRIl transcripts desi-
gned horizontal arrows position -47 -61. closed circles position +1373 (t 1) indicate 31 end-point PRIl mRNA. 6 bp
restriction endonuclease recognition sites indicated sequence.
 frame translation start sites located 60 bp apart, shown set HTS1 transcripts initiates upstream ATG codons, set initiates ATGs, messages encode t-ihe


                                                                                                                                                  7981
 Nucleic Acids Research
mitochondrial cytoplasmic hystidine-tRNA synthetase, respectively (12). transcription mapping PRIl mRNA   places 5' end-
points transcripts upstream ATG codon, necessa-
ry destroy ATGs vitro mutagenesis construct PRIl-lacZ
fusions include frame ATGs assess role initiation translation. Recent examination ribosome
scanning hypothesis (18) indicates  AUG lies unfa-
vorable nucleotide context reading frame second
AUG codon, ribosomes initiate sites, producing long short
versions encoded polypeptide, case PRIl
gene. optimal context initiator AUG codon higher eukaryotes CCACCAUGG (16), consensus sequence AUG context highly
expressed yeast genes AAAAAAAUGUC (17). sequences possible translation initiation codons PRI1. 72 bp long
ORF present upstream 5' transcription start position -201 -126.  function,  short ORF  present,
unknown.
Codon usage PRIl predicted structure gene product. shown Table 1, translation 1,227 bp ORF PRIl gene
indicates PRIl protein 40.3  non polar, 27.9  polar, 17.1  posi-
tively charged 14.7  negatively charged amino acids. represents random distribution types amino acids. Table 1 shows frequency codon usage. shown correlation extent codon bias gene level mRNA protein expression (19,20). examination codon usage PRIl
gene reveals tha little codon bias. fact, CGC arginine codon, 60 possible codons used PRI1. pattern codon usage common poorly expressed yeast genes agreement observation PRIl mRNA low abundance. 
don usage highly expressed ADH1 gene shown Table 1 faci-
litate direct comparison (27).




7982
                                                                                                   Nucleic Acids Research

                                                              Table 1.  Codon usae PRIA protein.
                        Po11                           ADNI                                poll                          ADN 
                                                                           M IUsage Ue*
                                                                              Cede" Ud  ACede.                          Cedon
                                                                                                                         Usage
                            L.         zu0::        Usage

Phe(F      )     TII          10('2.4)     46           0           Tyr(Y)     TAT            11(?.7)         73            0
Pbe             T.TC          11(2.7)      5?         100           Tyr        IAC             4( 1.0)        27          100
ieu(t)           TTA          11(2.7)      28                     Term       ]AA
teo             11T           13(3.?)      33          79           Tera       TAG

teo             CIl            4(1.0)       10          O           NHis(s)    CAl                6(1.5)       67           9
Lev             CiC            4(1.0)       10          0           Nis        CAC                3(0.7)       33          91
teo             CTA            3(0.7)                  13           GIn(0)     CAA            13(3.2)          87         100
ter             CTG            4(1.0)       10          0           6 n        CAG                2(0.5)       13           0

Ile(1)           ATT          12(2.9)      53          42           Asn(b)     AAT            13(3.2)          62           0
Ile              ATC           4(1.0)       16         57           Asn        AAC             8(2.0)          38         100
11e              ATA           6(1.S)       27          0           Lys(K)     AAA            19(4.6)          53          17
 *et           AT6           9(2.2)      100        100            Lys       AAG            17(4.2)          47          83

Va1(V)           CTT           4(1.0)       21         53            Asp(D)    CAT            25(6.1)          71          13
Va1              CTC           3(0.7)       16         47            Asp       GAC            10(2.4)          29          87
Val              CTA           5(1.2)       26          0            61u(E)    GAA            18(4.4)          72         100
Va1              GTG           7(1.7)       37          0            61u       GAG             7(1.7)          28           0

Set(S)           TCT           9(2.2)       31         67            Cys(C)    161                5(1.2)       63         100
Ser              TCC           3(0.7)       10         33            Cys       TIC                3(0.7)       37           0
Ser               TCA          8(2.0)       26          0            Term      TCA
Ser              TCC           3(0.7)       10          0            Trp(U)    TGG                7(1.7)      100         100

Pro(P)           CCT           12(2.9)      55         15            Arg( R)   CG1                5(1.2)       20           0
Pro              CCC            2(0.5)       9          8            Arg       CGC                0(0.0)        0           0
Pro              CCA            5(1.2)      23         77            Arg       CGA                2(0.5)        8           0
Pro              CCC            3(0.7)      14          0            Arg       CG6                ?(0.5)        6           0

  Thr( )         ACT            5( .2)      31         36            Ser       AGT                 1(0.2)       3           0
 Ihr             ACC            1(0.2)       6         64            Ser       AGC                 5(1.2)      17           0
 Ibr             ACA            5(1.2)      31          0            Arg       AGA                10(2.4)      40         100
 Tir             ACG            5(1.?)      31          0            Arg       AGG                 6(1.5)      24           0

 Ala            Cci          12(2.9)      46         54            CIy(C)
                                                                         G       C1                6( 1.5)     60          93
 Ala              CCC           6(1.5)      23         46            Gly       GGC                 1(0.2)      10
 Ala             6CA            7(1.7)      27          0            GIy        CGA                1(0.2)      10               0
 Ala             GCC            1(0.2)           4      0            Gly       CGC                 2(0.5)      20               0


 D. Predicted mino acid composition PRII protein
  Amime         Acid                  Amine Acid        t     Amino Acid                     Amino Acid                t
          Ala           26      6.4         CIN       15      3.7        Ler          39      9.S            Ser     29             7.1
                      25     6.1         CIl       25      6.1        Lys          36      6.6            Tlr     16             3.9
                     721     5.1          C1y      10      2.4        met           9          2.7        Trp      7             1.7
          Asp           35       6.6        Nis        9      2.7        Phe          21      5.1            lyr                 3.7
          Cys                   7.0         11e       22      5.4        Pro          722     S.4            V1      19             4.6




                                                                                                                                     7983
 Nucleic Acids Research

                              Ix               v    B     T               B            c       v     B   

                                                                                                                        


     0




                       s0           100          1S0            t00          to50          300             30             400



Figure 3. Hydrophilicity profile secondary structure mature PRIl
amino acids sequence predicted DNA sequence analysis. Positive nega-
tive numbers correspond hydrophilic hydrophobic regions, respectively
(22). = K-helix;     =   -sheet; T= 3-turn.
 local secondary structure hydrophilicity value PRI1 gene
product          predicted assisted analysis (21,22). shown Figure 3, regions                        CK-helical structure                10               contigous
amino acids                located residues 43-52, 94-114, 136-151, 214-233, 294-313,
320-329, 354-363, 387-403. longest contigous >-turns                                                    p-sheets        

gions        located residues 124-135 179-195, respectively. hydro-
philicity index PRIl protein (Figure 3),                                                      hydrophilicity values shown useful predict protein
antigenic determinants amino acids                               sequences      (22). fact, point highest local average hydrophilicity invariably located                                                      adjacent        antigenic determinant. attempts produce specific monoclonal antibo-
bies DNA primase mojety yeast DNA polymerase-DNA primase
complex                     unsuccessful (7).                use           proper        synthetic    pep-

tides derived PRIl sequence possibly help                                                reach goal. specific immunological reagents                                    useful purifying yeast
proteins interacting vivo DNA primase. fact, yeast DNA polyme-
rase-primase complex itself                        purified using               monoclonal antibody raised isolated DNA polymerase                          (3).
Transcription mapping PRIl                          gene.

Poly        RNA prepared Saccharomyces cerevisiae strain TD28                                                  used 


7984
                -80




               60  



               - 40




methods allow                           .':W
                          12




                          V:
                            



                          .f.;.- X




                           : :




                         measure
                                 .9wF




                                _:
                                 _




                                  s
                                    ..


                                   ....:;
                                    ::.:..


                                    .:::S


                                  !:'.:.:.F:


                                    .                                         '


                                   .:: '.
                                  ..}.e
                                  .:::,f
                                 .. -.e.:e,



                               .. m R,.
                                         ....




                                         ::




                            *: . ::. Bbres
                                    .X#,,




                                     .:}}::.::
                                    .:!: .^.
                                   *;:S::
                                              .:.




                                              ..




                                   .'.S2}3}. '.




                                          :::::..
                                                          12




                                                          . . :.:.
                                                          . . . . . . .                                                            . '.........
                                                          *..




Figure 4. Determination 5' 3' end-points mature PRIl
transcript. 5' termini PRIl transcripts mapped Sl prote-
ction (Panel  primer extension (Panel B), according procedures
described Materials Methods. Panel C, shows Sl mapping 3'
end-point PRIl transcription. Lanes 1 2 results obtained using 20 40 jg, respectively, poly  RNA Sl mapping primer extension experiments. treatment Sl, protected fragments run 6  sequencing gel (Panel C). products primer
extension shown Panel B analyzed 8  sequencing gel.

Sl mapping experiments (23) primer extension AMV
                                                             B




                                                             .... . .'.:..^...,.:.
                                                                    ..




criptase (24) identify 5' end-points mature PRIl message.                                                                               ..
                                                                            ...:
                                                                                     -100


                                                                                     -80



                                                                                     -60




                                                                                     -40
                                                                                                1 2




                                                    distance 5' mRNA terminus                                                                                                     C
                                                                                                        Nucleic Acids Research




                                                                                                           +1400
                                                                                                           +1380

                                                                                                           +1360

                                                                                                           41340


                                                                                                           +1320



                                                                                                            +1300




                                                                                                            +1280




                                                                                                               reverse   trans-


                                                                                                                            site
 exact position sequence known.   map   5' terminus Sl digestion, plasmid pPPl                                              cut ScaI, 5' end
labeled T4 polynucleotide kinase                                               [32P]-ATP   NruI-ScaI frag-

ment     used     probe. shown Figure 4, Sl mapping 5' terminus


                                                                                                                              7985
 Nucleic Acids Research

identifies major bands corresponding mRNA start sites position
-61 -47 strength signal dependent concentra-
tion   poly +   mRNA. existance transcription initiation points confirmed primer extension experiments, using synthetic oligonucleotide complementary nucleotide +1 +20 mRNA sequence incubated poly 
RNA presence reverse transcriptase triphosphates (Figure 4).  intensity signals increased doubling RNA concentra-
tion. comparison number yeast leader sequences shows transcription
initiation occurs nucleotide sequence PyAAPu (25), does strict rule, yeast genes initiate transcription different nucleotide context (14). sequence GAAAAG PRIl
upstream transcription start related sequence GAAG 5'
end CDC9 (DNA ligase) mRNA (27). similar motif present PRIl position -126 -121 sequences GAAG, GAAAG, GAAAAG 5' non coding region yeast genes CDC8 (thymidylate
kinase) CDC9 (26,27). PRIl gene periodically transcribed G1/S phase boundary interval yeast DNA synthesis genes
CDC8, CDC9, CDC21 (thymidilate synthetase) POLl (DNA polymerase  (28). complete sequence deletion analysis data available, compa-
rison upstream regions genes eventually identify sequence
similarities suggesting possible common regulatory mechanisms. consensus sequence TATAAA (29) yeast TATA box PRIl gene 5' transcription start, identical sequence located position -10 -5. yeast genes characterized date, TATA
like sequences quite hetherogeneous distances varying 50-150 nucleotides transcription start (30). Furthermore, poorly expressed yeast genes recognisable TATA homology
(31), appears case PRIl gene, CDC9 TOP2 genes (14,27). reason, se-
quence complementary yeast 18S rRNA (32) low-
ly expressed yeast genes.  PRIl 5' non coding region high

7986
                                                        Nucleic Acids Research
 T content, typical yeast promoter regions (17). position -200 -1 T composition 67.5  compared 56.5  PRIl coding region. determination 3' end-point PRIl transcript performed labeling plasmid pPPl NdeI site using NdeI-SstI fragment probe S1 nuclease protection experiments. shown Figure 4
panel C, 3' end-point PRIl transcript maps position +1373(±l). site located 142 bp TGA termination codon. sequence termination codon 3' end-point 64  T, characteri-
stic commonly yeast genes. specific signals responsible polyadenylation transcription termination Saccharomyces cerevisiae defined. Sequences similar consensus elements proposed Bennetzen Hall (33), Zaret Sherman (34) Henikoff et al. (35) readily apparent 3' non coding region PRIl gene, presence short runs T residues region termina-
tion codon 3' end-point. sequence AATAA, necessary polyadenylation genes higher eukaryotes (34), larger sequence located position +1251 +1258. deletion ana-
lysis 3' region PRIl gene nuclear runoff experiments necessary determine effect specific sequences PRIl transcript
stability translation efficiency distinguish poly-
adenylation termination transcription. PRIl gene yeast Saccharomyces cerevisiae sequenced
gene related eukaryotic DNA primase. search possible homology prokaryotic DNA primases E.coli dnaG protein (36), T7
gene 4 protein (37) T4 genes 41 61, did reveal signifi- homology. polypeptide structure eukaryotic DNA primases highly conserved. fact, DNA primase associated 48 kDa 58 kDa
polypeptides DNA polymerase-DNA primase complexes purified seve-
ral eukaryotic organisms (2). eukaryotic DNA primase genes identified characterized, interesting evaluate conserved structure mantained amino acids level,



                                                                             7987
 Nucleic Acids Research defining possible functional domains            essential   enzyme   involved initiation DNA replication.

ACKNOWLEDGMENTS work     partially supported      grant Progetto Finalizzato Inge-
gneria Genetica     e   Basi Molecolari delle Malattie Ereditarie, CNR, Roma, Italy.


 corrspondence adWessed

REFERENCES
 1. Kornberg  (1980) DNA replication, W.H.Freeman ,San Francisco.
 2. Campbell.J.L. (1986) Ann.Rev.Biochem. 55, 733-771
 3. Plevani,P.,Foiani,M.,Valsasnini,P.,Badaracco,G.,Cheriathundam,E.      Chang,L.M.S. (1985) J.Biol.Chem. 260, 7102-7107.
 4. Lucchini,G.,Francesconi,S.,Foiani,M.,Badaracco,G. Plevani,P. (1987)
     EMBO J. 6, 737-742.
 5. Lucchini,G.,Brandazza ,Badaracco,G.,Bianchi,M. Plevani,P. (1985)
     Curr.Genet. 10, 245-252.
 6. Johnson,L.M.,Snyder,b.,Chang,L .M.S.,Davis,R.W. Campbell,J.L. (1985)
     Cell. 43, 369-377.
 7. Plevani,P. ,Lucchini,G.,Foiani,M.,Valsasnini,P.,Brandazza ,Bianchi,M.,
     Magni,G. Badaracco,G. (1987) Life Sci.Adv. 6, 53-60.
 8. Badaracco,G.,Valsasnini,P.,Foiani,M.,Benfante,R.,Lucchini,G. Plevani,?P
     (1986) Eur.J.Biochem. 161, 435-440.
 9. Henikoff,S. (1984) Gene. 28, 351-359.
10. Sanger,F.,Nicklen,S. Coulson R. (1977) Proc.Natl.Acad.Sci.USA. 74,
     5413-5417.
11. Hattori,M. Sakaki,Y. (1986) Anal.Biochem. 152, 232-238.
12. Natsoulis,G.,Hilger,F. Fink,G.R. (1986) Cell. 46, 235-243.
13. Maxam  Gilbert,W. (1980) Methods Enzymol. 65, 499-560.
14. Giaver,G.,Lynn,R.,Goto,T. Wang,J.C. (1986) J.Biol.Chem. 261, 12448-
     12454.
15. Strauss,E.C.,Ko